Both are built on two sets of variables: a clinical set and an extended set, which enriches the former with biomarker data, namely CD171 (L1CAM, L1 cell adhesion molecule expression), estrogen receptor (ER) status, peritoneal washing and tumor size. The gene discussed is L1CAM; the disease is neoplasm.